Immunovia AB (publ) Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Patrik Dahlen, was filed 19 Jan 2021.
Immunovia AB (publ): what insiders have been doing
This page follows insider dealings at Immunovia AB (publ) as filed with Finansinspektionen, a company from the Health Care sector. Nothing new has been filed by managers of Immunovia AB (publ) in twelve months, the latest record being from 19 January 2021.
Looking back to 2021, when coverage begins, insiders filed 2 purchases and no sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Financial data
as of FY 2025FY ended December 2025 · cache
- 250,000 shares@ SEK 1.57100.0% of flowTeckningsoptionISIN SE0006091997FI:A001P618-1Canonical exit: 15 Apr 2021 (T+90)
- 2,000 shares@ SEK 1.57100.0% of flowTeckningsoptionISIN SE0006091997FI:A001P617-1Canonical exit: 15 Apr 2021 (T+90)
2 of 2 declarations
About Immunovia AB (publ)
Immunovia AB (publ) is a Swedish company focused on developing diagnostic tests for cancer. It aims to improve patient outcomes through innovative solutions.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
